- Home
- EQBK vs ZVRA Comparison
EQBK vs ZVRA Comparison
Compare EQBK & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQBK
- ZVRA
- Stock Information
- Founded
- EQBK 2002
- ZVRA 2006
- Country
- EQBK United States
- ZVRA United States
- Employees
- EQBK N/A
- ZVRA N/A
- Industry
- EQBK Major Banks
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- EQBK Finance
- ZVRA Health Care
- Exchange
- EQBK Nasdaq
- ZVRA Nasdaq
- Market Cap
- EQBK 696.9M
- ZVRA 627.7M
- IPO Year
- EQBK 2015
- ZVRA 2015
- Fundamental
- Price
- EQBK $41.44
- ZVRA $9.44
- Analyst Decision
- EQBK Buy
- ZVRA Strong Buy
- Analyst Count
- EQBK 6
- ZVRA 10
- Target Price
- EQBK $45.60
- ZVRA $22.67
- AVG Volume (30 Days)
- EQBK 91.8K
- ZVRA 1.6M
- Earning Date
- EQBK 10-14-2025
- ZVRA 08-12-2025
- Dividend Yield
- EQBK 1.52%
- ZVRA N/A
- EPS Growth
- EQBK 532.31
- ZVRA N/A
- EPS
- EQBK 4.01
- ZVRA N/A
- Revenue
- EQBK $227,628,000.00
- ZVRA $62,020,000.00
- Revenue This Year
- EQBK $19.34
- ZVRA $303.00
- Revenue Next Year
- EQBK $11.25
- ZVRA $77.66
- P/E Ratio
- EQBK $9.85
- ZVRA N/A
- Revenue Growth
- EQBK 48.83
- ZVRA 161.81
- 52 Week Low
- EQBK $34.11
- ZVRA $6.19
- 52 Week High
- EQBK $50.85
- ZVRA $13.16
- Technical
- Relative Strength Index (RSI)
- EQBK 65.30
- ZVRA 39.30
- Support Level
- EQBK $39.08
- ZVRA $8.91
- Resistance Level
- EQBK $40.29
- ZVRA $10.15
- Average True Range (ATR)
- EQBK 0.83
- ZVRA 0.65
- MACD
- EQBK 0.42
- ZVRA -0.22
- Stochastic Oscillator
- EQBK 99.42
- ZVRA 22.80
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.